1.20

8.40% -0.11

Accendra Health Inc (ACH)

Overview News Price History Discussions Forecast Dividend History

Accendra Health Inc stock is traded at $1.20, with a volume of 1.69M. It is down -8.40% in the last 24 hours and down -64.91% over the past month. Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.

Previous Close:

$1.31

Open:

$1.28

24h Volume:

1.69M

Relative Volume:

1.55

Market Cap:

$92.29M

Revenue:

$4.72B

Net Income/Loss:

$-123.85M

P/E Ratio:

-0.0839

EPS:

-14.2981

Net Cash Flow:

$-303.12M

1W Performance:

+26.20%

1M Performance:

-64.91%

6M Performance:

-54.02%

1Y Performance:

-82.02%

1-Day Range:

$1.175

$1.31

1-Week Range:

$0.95

$1.37

52-Week Range:

$0.9337

$4.6887

Accendra Health Inc Stock (ACH) Company Profile

Name

Accendra Health Inc

Sector

Healthcare (1080)

Industry

Medical Distribution (12)

Phone

(804) 277-4304

Address

4435 WATERFRONT DRIVE, GLEN ALLEN

Employee

6,500

Twitter

Next Earnings Date

2026-08-10

Latest SEC Filings

ACH's Discussions on Twitter

Compare ACH vs MCK, COR, CAH, HSIC, AHG

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ACH Accendra Health Inc	1.20	100.75M	4.72B	-123.85M	-303.12M	-14.30
MCK Mckesson Corp	858.90	97.79B	403.43B	5.10B	5.41B	38.47
COR Cencora Inc	318.04	60.05B	328.68B	2.55B	1.56B	13.03
CAH Cardinal Health Inc	229.51	53.13B	250.74B	1.55B	4.39B	6.5398
HSIC Henry Schein Inc	88.50	9.86B	13.38B	418.00M	391.00M	3.3112
AHG Akso Health Group Adr	0.9297	873.84M	14.85M	-136.07M	7.25M	-0.4726

Accendra Health Inc Stock (ACH) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-03-25	Downgrade	UBS	Buy → Neutral
Jul-19-24	Upgrade	Citigroup	Neutral → Buy
Feb-26-24	Initiated	Leerink Partners	Market Perform
Jan-03-24	Initiated	Barclays	Equal Weight
Oct-13-22	Downgrade	Citigroup	Buy → Neutral
Oct-12-22	Downgrade	BofA Securities	Buy → Underperform
Oct-12-22	Downgrade	Robert W. Baird	Outperform → Neutral
Apr-26-22	Resumed	Citigroup	Buy
Apr-01-22	Resumed	Credit Suisse	Neutral
Mar-30-22	Resumed	JP Morgan	Underweight
Mar-23-22	Upgrade	HSBC Securities	Reduce → Hold
Apr-08-21	Upgrade	JP Morgan	Neutral → Overweight
Mar-08-21	Upgrade	Goldman	Sell → Buy
Dec-17-20	Upgrade	UBS	Neutral → Buy
Sep-25-20	Upgrade	Barclays	Underweight → Equal Weight
Jul-21-20	Upgrade	BofA Securities	Neutral → Buy
Jul-21-20	Upgrade	Robert W. Baird	Neutral → Outperform
Jul-14-20	Upgrade	Credit Suisse	Neutral → Outperform
May-05-20	Downgrade	Robert W. Baird	Outperform → Neutral
Apr-23-20	Resumed	Credit Suisse	Neutral
Jan-21-20	Upgrade	Robert W. Baird	Neutral → Outperform
Jan-07-20	Downgrade	Goldman	Neutral → Sell
Nov-15-19	Upgrade	CLSA	Underperform → Outperform
Sep-06-19	Reiterated	BofA/Merrill	Neutral
Apr-10-19	Reiterated	BofA/Merrill	Neutral
Apr-03-19	Upgrade	BofA/Merrill	Neutral → Buy
Apr-01-19	Upgrade	JP Morgan	Underweight → Overweight
Jan-18-19	Upgrade	HSBC Securities	Hold → Buy
Jan-17-19	Initiated	UBS	Neutral
Jan-15-19	Upgrade	CLSA	Underperform → Outperform
Dec-14-18	Downgrade	Morgan Stanley	Overweight → Underweight
Dec-12-18	Downgrade	Goldman	Buy → Neutral
Sep-28-18	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Apr-11-18	Downgrade	CLSA	Outperform → Sell
Apr-10-18	Upgrade	Credit Suisse	Neutral → Outperform
Mar-26-18	Upgrade	Goldman	Sell → Neutral
Nov-02-17	Downgrade	HSBC Securities	Buy → Hold
Mar-24-16	Upgrade	Goldman	Sell → Neutral
Dec-07-15	Downgrade	Goldman	Neutral → Sell
Aug-31-15	Upgrade	Credit Suisse	Underperform → Neutral
Aug-01-12	Initiated	HSBC Securities	Underweight
Aug-05-09	Upgrade	Citigroup	Sell → Buy
Dec-01-08	Downgrade	HSBC Securities	Neutral → Underweight

View All

Accendra Health Inc Stock (ACH) Latest News

Aug 19, 2026

Accendra (ACH) Quarterly Figures: EPS Does Not Reach the Reported Estimate under the Current Snapshot; Stock Move: The Stock Gains 5.61% for the Current SessionBasic EPS Analysis - vinanet.vn

Aug 19, 2026

Aug 18, 2026

Accendra Health Inc (NYSE: ACH) Share Price, ACH Stock News, ACH Share Price & Updates - Kalkine

Aug 18, 2026

Aug 17, 2026

Accendra Health scraps equity program, expects CEO successor By Investing.com - Investing.com South Africa

Aug 17, 2026

Accendra Health Drops Equity Issuance Plan, Targets September CEO Announcement - citybiz

Aug 17, 2026

Accendra Health drops equity issuance plan as CEO succession process advances - Yahoo Finance

Aug 17, 2026

Accendra Health scraps equity program, expects CEO successor - Investing.com

Aug 17, 2026

Form 8K Accendra Health Inc For: 17 August By Investing.com - Investing.com Nigeria

Aug 17, 2026

Accendra Health sells first of two non-core assets, expects about $45 million cash injection - Bitget

Aug 17, 2026

Accendra Health to forgo ATM program, sees ~$45M from two asset sales; CEO successor expected by mid-September - TradingView

Aug 17, 2026

Accendra Health Updates on Capital Allocation and CEO Succession Timing Plans - Yahoo Finance

Aug 17, 2026

Aug 14, 2026

Accendra Health ready to put weak Q2 in rear view - HME News

Aug 14, 2026

Accendra Health (ACH) Drops 9% to $1.10 as Selling Pressure PersistsAnchored VWAP - vinanet.vn

Aug 14, 2026

Accendra Health 2Q Loss/Shr $1.16 >ACH - Moomoo

Aug 14, 2026

Aug 12, 2026

Accendra Health (NYSE:ACH) Rating Lowered to "Hold" at Robert W. Baird - MarketBeat

Aug 12, 2026

Dimensional Fund Advisors LP Buys Shares of 2,606,620 Accendra Health, Inc. $ACH - MarketBeat

Aug 12, 2026

Aug 11, 2026